Filing Flows › biote (BTMD) › Q2 2026
biote (BTMD) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 7, 2026
biote (BTMD) reported revenue of $44.2M for the second quarter 2026 (Q2 2026), -9% from a year earlier and -2% from the quarter before. Operating margin was -7.9%, net loss $7.4M (16.8% of revenue).
biote, Q2 2026: revenue $44.2M (-10% year over year), operating margin -7.9%, net loss $7.4M, operating cash flow −$1.2M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $44.2M | -2% | -9% |
| Operating profit | −$3.5M | -211% | -133% |
| Net earnings | −$7.4M | -426% | -333% |
| Operating cash flow | −$1.2M | -130% | -117% |
What changed
Revenue was $44.2M in Q2 2026, down 9% year over year and down 2% from the previous quarter. Pellet Procedures Product Revenue was the largest line at 69% of revenue. Pellet Procedures Product Revenue lost $4.9M year over year (down 14%), 106% of the total change.
Operating costs exceeded revenue by $3.5M, an operating margin of -7.9%. Total costs grew 25% against a revenue fall of 9%. The fastest-growing cost line was SG&A (+34%). The quarter ended with a net loss of $7.4M, after a profit of $2.7M the previous quarter. Minority interests bore $865K of it: to shareholders the quarter was a loss of $6.6M.
Operating cash flow was −$1.2M. Non-cash charges added back $1.0M of depreciation and amortization and $2.0M of share-based compensation. Working capital and other items added $3.3M. Capital expenditures of $2.6M exceeded it, leaving free cash flow of −$3.7M.
Questions
What was biote's revenue in the second quarter 2026?
biote (BTMD) reported revenue of $44.2M for the second quarter 2026 (Q2 2026), -9% from a year earlier and -2% from the quarter before.
Was biote profitable in the second quarter 2026?
Operating loss was $3.5M (-7.9% of revenue) and net loss $7.4M.
Source: biote 10-Q on SEC EDGAR.